Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2018 1
2019 3
2020 4
2021 6
2022 7
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Reply to Caldwell et al.
Satlin MJ, Chen L, Douglass C, Hovan M, Davidson E, Soave R, La Spina M, Gomez-Arteaga A, van Besien K, Mayer S, Phillips A, Hsu JM, Malherbe R, Small CB, Jenkins SG, Westblade LF, Kreiswirth BN, Walsh TJ. Satlin MJ, et al. Among authors: gomez arteaga a. Clin Infect Dis. 2022 Aug 24;75(1):180-181. doi: 10.1093/cid/ciab1001. Clin Infect Dis. 2022. PMID: 34864913 Free PMC article. No abstract available.
Minimal Residual Disease in Acute Myeloid Leukemia.
Gomez-Arteaga A, Guzman ML. Gomez-Arteaga A, et al. Adv Exp Med Biol. 2018;1100:111-125. doi: 10.1007/978-3-319-97746-1_7. Adv Exp Med Biol. 2018. PMID: 30411263 Review.
Measurable residual disease after CAR T-cell therapy.
Chokr N, Gomez-Arteaga A. Chokr N, et al. Among authors: gomez arteaga a. Semin Hematol. 2023 Jan;60(1):34-41. doi: 10.1053/j.seminhematol.2023.02.001. Epub 2023 Feb 19. Semin Hematol. 2023. PMID: 37080709 Review.
Approaches to Targeting Cancer Stem Cells in Solid Tumors.
Caldas-Lopes E, Gomez-Arteaga A, Guzman ML. Caldas-Lopes E, et al. Among authors: gomez arteaga a. Curr Stem Cell Res Ther. 2019;14(5):421-427. doi: 10.2174/1574888X14666190222164429. Curr Stem Cell Res Ther. 2019. PMID: 30806324 Review.
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
Gomez-Arteaga A, Orfali N, Pasciolla M, Baptiste A, Guindine I, Hsu J, Lin J, Mayer SA, Phillips AA, Shore TB, Simonson PD, DiCarlo E, Yoon S, Muthukumar T, van Besien K. Gomez-Arteaga A, et al. Bone Marrow Transplant. 2023 Jul;58(7):835-838. doi: 10.1038/s41409-023-01981-x. Epub 2023 Apr 12. Bone Marrow Transplant. 2023. PMID: 37045941 No abstract available.
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome.
Hammond TC, Purbhoo MA, Kadel S, Ritz J, Nikiforow S, Daley H, Shaw K, van Besien K, Gomez-Arteaga A, Stevens D, Ortuzar W, Michelet X, Smith R, Moskowitz D, Masakayan R, Yigit B, Boi S, Soh KT, Chamberland J, Song X, Qin Y, Mishchenko I, Kirby M, Nasonenko V, Buffa A, Buell JS, Chand D, van Dijk M, Stebbing J, Exley MA. Hammond TC, et al. Among authors: gomez arteaga a. Nat Commun. 2024 Feb 6;15(1):974. doi: 10.1038/s41467-024-44905-z. Nat Commun. 2024. PMID: 38321023 Free PMC article. Clinical Trial.
Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop.
Auletta JJ, Holter-Chakrabarty J, Jain T, Miller B, Ward E, Khera N, Gomez-Arteaga A, Hall A, Nemecek E, Robb D, Yusuf RA, Davies SM; ACCESS Workshop Team Members. Auletta JJ, et al. Among authors: gomez arteaga a. Transplant Cell Ther. 2023 Dec;29(12):739-746. doi: 10.1016/j.jtct.2023.09.026. Epub 2023 Oct 5. Transplant Cell Ther. 2023. PMID: 37805142
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, Zhang MJ, Bo-Subait K, Sanchez J, Wang HL, Aljurf M, Assal A, Bacher VU, Badawy SM, Bejanyan N, Bhatt VR, Bredeson C, Byrne M, Castillo P, Cerny J, Chhabra S, Ciurea SO, DeFilipp Z, Farhadfar N, Gadalla S, Gale RP, Ganguly S, Gowda L, Grunwald MR, Hashmi S, Hildebrandt G, Kanakry CG, Kansagra A, Khimani F, Krem M, Lazarus H, Liu H, Martino R, Michelis FV, Nathan S, Nishihori T, Olsson R, Reshef R, Rizzieri D, Rowe JM, Savani BN, Seo S, Sharma A, Solh M, Ustun C, Verdonck LF, Hourigan C, Sandmaier B, Litzow M, Kebriaei P, Weisdorf D, Zhang Y, Tallman MS, Saber W. Menghrajani K, et al. Among authors: gomez arteaga a. Blood Adv. 2022 Jan 8;6(3):828-847. doi: 10.1182/bloodadvances.2021004881. Blood Adv. 2022. PMID: 34551064 Free PMC article.
25 results